4Filed Mar 12, 8:00 PM ET

Mentor Capital (MNTR) CEO Chester Billingsley Buys 3,550 Shares

$MNTR · Mentor Capital, Inc.

Research Summary

AI-generated summary of this SEC filing

Updated

Mentor Capital (MNTR) CEO Chester Billingsley Buys 3,550 Shares

What Happened
CEO Chester Billingsley reported three purchases of Mentor Capital (MNTR) stock (transaction code P — purchase). He bought 2,450 shares on 2026-03-11, 1,000 shares on 2026-03-12, and 100 shares on 2026-03-13, each at $0.08 per share. The filing shows reported totals of $205, $83, and $8 respectively, for a combined reported cost of $296. These were purchases (buying stock), which some investors view as a more informative signal than routine insider sales.

Key Details

  • Transaction dates and prices: 2026-03-11 — 2,450 shares @ $0.08 ($205 reported); 2026-03-12 — 1,000 shares @ $0.08 ($83 reported); 2026-03-13 — 100 shares @ $0.08 ($8 reported).
  • Total acquired: 3,550 shares; total reported amount: $296.
  • Transaction code: P = Purchase (open market or private purchase as reported).
  • Shares owned after transaction: Not specified in the provided Form 4 information.
  • Footnotes: F1–F2 describe Series Q Convertible Preferred stock conversion mechanics (convertible into common at holder’s option, conversion-price formula tied to a 105% multiplier of a designated closing price, quarterly valuation of conversion value). As of 12/31/2025, 11 Series Q shares were eligible to convert into 2,592,159 common shares. These footnotes relate to convertible preferred terms, not the reported common-stock purchases.
  • Filing: Form 4 filed 2026-03-13 for trades from 2026-03-11 to 2026-03-13 — appears to be filed within the normal Form 4 reporting window (not marked late).

Context
The total dollar amount is small (under $300 reported), so while purchases are generally more notable than sales, this is a modest insider buy and may not by itself indicate a material change in insider conviction. The Series Q preferred-share footnotes describe potential significant dilution if converted, which is relevant to shareholders but separate from these small common-stock purchases.